Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertelsmann

Showing results (71-80 of 366) with videos related to

Pageof 37
Sort By:
European Journal of Immunology|March 1, 1989
Production of macrophage-, granulocyte-, granulocyte-macrophage- and multi-colony-stimulating factor by peripheral blood cellsW Oster, A Lindemann, R Mertelsmann, et al.
Seminars in Oncology|August 1, 1992
In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cellsF Herrmann, W Brugger, L Kanz, et al.
FEBS Letters|August 1, 1998
Expression of functional receptors for interleukin-6 by human polymorphonuclear leukocytes. Downregulation by granulocyte colony-stimulating factorR Mertelsmann, A Lindemann, R Henschler, et al.
Bone Marrow Transplantation|August 1, 1990
Hematopoietic growth factors in bone marrow transplantationR Mertelsmann, F Herrmann, T Hecht, et al.
Bone Marrow Transplantation|June 1, 1997
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicityH Bertz, K Potthoff, R Mertelsmann, et al.
The British Journal of Dermatology|May 15, 1998
Leg ulceration with associated thrombocytosis: healing of ulceration associated with treatment of the raised platelet countK Wirth, E Schoepf, R Mertelsmann, et al.
Klinische Wochenschrift|August 15, 1975
[The effect of actinomycin d, acridine dyes and related substances on the biosynthesis of nucleic acids in normal and leukemic white blood cells. Comparative investigation in intact cells and in a cell-free system (author's transl)]B Benkert, R Neth, M Garbrecht, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Haematopoietic growth factors in clinical medicineR Henschler, W Brugger, L Kanz, et al.
Leukemia & Lymphoma|February 1, 1994
BCL-2 induction is part of the strategy of Epstein-Barr virusJ Finke, W Lange, R Mertelsmann, et al.
Molecular Pharmacology|February 1, 1991
Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosineR Henschler, U Brennscheidt, R Mertelsmann, et al.
Pageof 37

Showing results (71-80 of 366) with videos related to

Sort By:
Pageof 37
European Journal of Immunology|March 1, 1989
Production of macrophage-, granulocyte-, granulocyte-macrophage- and multi-colony-stimulating factor by peripheral blood cellsW Oster, A Lindemann, R Mertelsmann, et al.
Seminars in Oncology|August 1, 1992
In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cellsF Herrmann, W Brugger, L Kanz, et al.
FEBS Letters|August 1, 1998
Expression of functional receptors for interleukin-6 by human polymorphonuclear leukocytes. Downregulation by granulocyte colony-stimulating factorR Mertelsmann, A Lindemann, R Henschler, et al.
Bone Marrow Transplantation|August 1, 1990
Hematopoietic growth factors in bone marrow transplantationR Mertelsmann, F Herrmann, T Hecht, et al.
Bone Marrow Transplantation|June 1, 1997
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicityH Bertz, K Potthoff, R Mertelsmann, et al.
The British Journal of Dermatology|May 15, 1998
Leg ulceration with associated thrombocytosis: healing of ulceration associated with treatment of the raised platelet countK Wirth, E Schoepf, R Mertelsmann, et al.
Klinische Wochenschrift|August 15, 1975
[The effect of actinomycin d, acridine dyes and related substances on the biosynthesis of nucleic acids in normal and leukemic white blood cells. Comparative investigation in intact cells and in a cell-free system (author's transl)]B Benkert, R Neth, M Garbrecht, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Haematopoietic growth factors in clinical medicineR Henschler, W Brugger, L Kanz, et al.
Leukemia & Lymphoma|February 1, 1994
BCL-2 induction is part of the strategy of Epstein-Barr virusJ Finke, W Lange, R Mertelsmann, et al.
Molecular Pharmacology|February 1, 1991
Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosineR Henschler, U Brennscheidt, R Mertelsmann, et al.
Pageof 37